Somatotropin Penetration Testing from Formulations Applied Topically to the Skin

Somatotropin Penetration Testing from Formulations Applied Topically to the Skin

Growth hormone (somatotropin—STH) deficiency therapy requires daily injections of recombinant human growth hormone. The FDA approved treatment with STH with one dose per week for the first time in 2021. However, injectable drug application is accompanied by numerous inconveniences. Therefore, an att...

Full description

Bibliographic Details
Main Authors: Wioletta Siemiradzka, Agata Franczyk, Lucyna Bułaś, Barbara Dolińska
Format: Article
Language:English
Published: MDPI AG 2023-02-01
Series:Applied Sciences
Subjects:
somatotropin
albumin
drug delivery
prolonged effect
topical application
skin permeation
Online Access:https://www.mdpi.com/2076-3417/13/4/2588

Similar Items

Similar Items